to close 95 stores Johnson & Johnson wants to pay $6.5B to settle talcum-powder lawsuits over cancer claims Currently, there are more than 700 Red Lobster locations around the world. Those Red ...
Johnson told reporters on May 6 he’s seeking $1 billion in commitments ... $30 million to $40 million flowing to the city. The city wants $14 million in funding to replace lead service lines ...
There are going to be winners, albeit at the heavy price of roughly $2.6 billion annually from ESPN and about $1.8B annually from Amazon. But the prospect of saying goodbye to WBD’s Turner, after a 35 ...
Johnson & Johnson, a name synonymous with household products, has recently made headlines with its monumental $6.475 billion settlement. This decision marks a pivotal chapter in the history of ...
Pharmaceutical giant Johnson & Johnson is set to pay $6.475 billion to settle lawsuits alleging its talc-based products, often associated with health concerns, caused cancer. This unprecedented ...
The fact that multiple Johnson & Johnson (NYSE:JNJ) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider ...
(Reuters) -Johnson & Johnson said on Thursday it would acquire Proteologix for $850 million in cash, as it looks to gain access to the privately held company's experimental atopic dermatitis ...
After Johnson & Johnson's consumer healthcare spinoff last year—and its subsequent reduction in holdings in the new company—the healthcare conglomerate is once again cutting its stake in Kenvue.
If we want our students to have an economic impact in high technology and interactive and digital media, gaming and esports ...
NEW BRUNSWICK, N.J. - Johnson & Johnson (NYSE: JNJ) announced it will acquire biotechnology firm Proteologix, Inc. for $850 million in cash, with the potential for additional milestone payments.